Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Harvoni in Treatment-Naive Alcoholic Subjects with Genotype 1 HCV
NCT02759861Phase 4Completed
- Sponsor
- University of Nebraska
- Start
- Aug 2016
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ledipasvir in hepatitis C (HCV), sponsored by University of Nebraska. Started Aug 2016; status: completed.
02
Drugs
ledipasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02759861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02759861.